協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/06/06 | 2,007 | 2,047 | 2,000 | 2,022 | +13 | +0.6% | 680,100 |
2019/06/05 | 2,012 | 2,036 | 2,004 | 2,009 | +4 | +0.2% | 841,700 |
2019/06/04 | 2,020 | 2,027 | 2,001 | 2,005 | -10 | -0.5% | 914,600 |
2019/06/03 | 2,019 | 2,023 | 1,995 | 2,015 | -35 | -1.7% | 861,900 |
2019/05/31 | 2,064 | 2,090 | 2,049 | 2,050 | -24 | -1.2% | 881,400 |
2019/05/30 | 2,077 | 2,084 | 2,062 | 2,074 | -28 | -1.3% | 616,000 |
2019/05/29 | 2,099 | 2,111 | 2,071 | 2,102 | -32 | -1.5% | 853,900 |
2019/05/28 | 2,125 | 2,144 | 2,120 | 2,134 | +11 | +0.5% | 1,938,300 |
2019/05/27 | 2,106 | 2,135 | 2,106 | 2,123 | +30 | +1.4% | 990,600 |
2019/05/24 | 2,070 | 2,094 | 2,058 | 2,093 | +17 | +0.8% | 1,264,900 |
2019/05/23 | 2,106 | 2,118 | 2,074 | 2,076 | -15 | -0.7% | 1,466,800 |
2019/05/22 | 2,070 | 2,105 | 2,050 | 2,091 | +56 | +2.8% | 1,811,600 |
2019/05/21 | 2,043 | 2,061 | 2,033 | 2,035 | -8 | -0.4% | 935,700 |
2019/05/20 | 2,020 | 2,052 | 2,016 | 2,043 | +28 | +1.4% | 768,500 |
2019/05/17 | 2,008 | 2,036 | 2,005 | 2,015 | +19 | +1% | 944,500 |
2019/05/16 | 1,986 | 1,998 | 1,969 | 1,996 | +2 | +0.1% | 1,154,200 |
2019/05/15 | 1,983 | 2,004 | 1,967 | 1,994 | +10 | +0.5% | 1,278,800 |
2019/05/14 | 1,961 | 1,990 | 1,955 | 1,984 | -8 | -0.4% | 1,043,100 |
2019/05/13 | 2,005 | 2,023 | 1,981 | 1,992 | -38 | -1.9% | 1,130,000 |
2019/05/10 | 2,040 | 2,065 | 2,006 | 2,030 | +6 | +0.3% | 1,322,400 |
2019/05/09 | 2,099 | 2,110 | 2,021 | 2,024 | -52 | -2.5% | 1,711,700 |
2019/05/08 | 2,111 | 2,111 | 2,063 | 2,076 | -59 | -2.8% | 1,143,700 |
2019/05/07 | 2,164 | 2,172 | 2,116 | 2,135 | -21 | -1% | 1,575,200 |
2019/04/26 | 2,109 | 2,159 | 2,097 | 2,156 | +38 | +1.8% | 1,495,100 |
2019/04/25 | 2,093 | 2,126 | 2,088 | 2,118 | +44 | +2.1% | 1,520,900 |
2019/04/24 | 2,109 | 2,125 | 2,057 | 2,074 | -4 | -0.2% | 1,745,200 |
2019/04/23 | 2,050 | 2,101 | 2,041 | 2,078 | +44 | +2.2% | 1,903,400 |
2019/04/22 | 2,016 | 2,042 | 2,012 | 2,034 | +4 | +0.2% | 895,700 |
2019/04/19 | 2,044 | 2,048 | 2,021 | 2,030 | -9 | -0.4% | 1,092,600 |
2019/04/18 | 2,087 | 2,087 | 2,034 | 2,039 | -63 | -3% | 1,600,400 |
2019/04/17 | 2,125 | 2,127 | 2,088 | 2,102 | -38 | -1.8% | 1,553,900 |
2019/04/16 | 2,141 | 2,151 | 2,125 | 2,140 | -15 | -0.7% | 780,600 |
2019/04/15 | 2,174 | 2,181 | 2,152 | 2,155 | +3 | +0.1% | 1,023,300 |
2019/04/12 | 2,214 | 2,215 | 2,146 | 2,152 | -53 | -2.4% | 1,034,300 |
2019/04/11 | 2,225 | 2,238 | 2,203 | 2,205 | -18 | -0.8% | 670,100 |
2019/04/10 | 2,238 | 2,254 | 2,222 | 2,223 | -34 | -1.5% | 750,900 |
2019/04/09 | 2,288 | 2,288 | 2,256 | 2,257 | -42 | -1.8% | 841,000 |
2019/04/08 | 2,335 | 2,336 | 2,292 | 2,299 | -32 | -1.4% | 943,100 |
2019/04/05 | 2,350 | 2,362 | 2,328 | 2,331 | -19 | -0.8% | 611,200 |
2019/04/04 | 2,401 | 2,403 | 2,346 | 2,350 | -49 | -2% | 955,500 |
2019/04/03 | 2,377 | 2,402 | 2,361 | 2,399 | +22 | +0.9% | 1,200,100 |
2019/04/02 | 2,442 | 2,445 | 2,373 | 2,377 | -31 | -1.3% | 1,116,500 |
2019/04/01 | 2,456 | 2,462 | 2,400 | 2,408 | -2 | -0.1% | 1,639,200 |
2019/03/29 | 2,348 | 2,410 | 2,341 | 2,410 | +94 | +4.1% | 1,956,200 |
2019/03/28 | 2,331 | 2,333 | 2,303 | 2,316 | -33 | -1.4% | 2,629,800 |
2019/03/27 | 2,343 | 2,358 | 2,330 | 2,349 | +10 | +0.4% | 1,345,800 |
2019/03/26 | 2,305 | 2,355 | 2,304 | 2,339 | +60 | +2.6% | 1,719,700 |
2019/03/25 | 2,311 | 2,320 | 2,276 | 2,279 | -42 | -1.8% | 1,205,900 |
2019/03/22 | 2,359 | 2,359 | 2,316 | 2,321 | -31 | -1.3% | 1,110,000 |
2019/03/20 | 2,382 | 2,388 | 2,344 | 2,352 | -15 | -0.6% | 1,080,600 |
1451~
1500
件表示中 / 3699件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 217,200円 | -3.5% | -11.3% | 2.76% | 19.95倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 134,100円 | +0.9% | +380.2% | 5.82% | 18.47倍 | 1.59倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 218,800円 | +20.9% | +10.6% | 3.02% | 10.34倍 | 1.37倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 366,700円 | +1.7% | -2.9% | 4.36% | 24.06倍 | 1.27倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 149,200円 | +0.6% | +43.3% | 5.36% | 10.46倍 | 0.89倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム